Metrics as of 10/17/2026, 02:51 AM (Berlin time), refresh in progress.
Drägerwerk Stock
Drägerwerk AG & Co. KGaA
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- Germany
- CEO
- Stefan A. Drager
- Employees
- 16,009
- Market cap
- €1.8 B
- IPO
- 12/11/1998
Headquartered in Lübeck, Germany, and established in 1889, Drägerwerk AG & Co. KGaA is an international enterprise specializing in medical and safety technology. The company operates across Europe, the Americas, Africa, Asia, and Australia. Within the healthcare sector, the firm engineers, produces, and commercializes…
Company description based on the data provider's company data, AI-assisted, created on 15/10/2026. Not investment advice.
Drägerwerk stock: price history
1D
-0.6%
1W
-17.9%
1M
-15.8%
6M
-3.7%
YTD
+37.9%
1Y
+26.4%
2Y
+116.3%
5Y
+38.7%
10Y
+54.1%
Next earnings date
Next earnings date
29/10/2026 (in 12 days)
Volatility around earnings
~6% weaker price swings than usual
Drägerwerk stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Business model & megatrends
Very robust business model with strong megatrend tailwind: wide moat, strong pricing power, predictable revenue.
1 more assignment (Enabler/Second row) Pro-only.
Drägerwerk AG & Co. KGaA is an internationally operating company with focus areas in medical technology and safety technology. The healthcare sector portfolio comprises specialized medical devices for acute care such as ventilators, anesthesia systems and patient monitors as well as software, consumables and services. In the safety segment, the company offers gas detection protection systems, personal protective equipment and hazard management solutions. These products and systems are used primarily in industry, mining and with blue light organizations such as fire departments and law enforcement. The business model is further complemented by training offerings.
- Revenue model
- Mixed
- Recurring revenue
- High
- Pricing power
- Strong
- Moat
- Wide
- Moat type
- Regulatory
- Capital intensity
- High
- Customer concentration
- Low
Ask the agents about Drägerwerk
Drägerwerk stock metrics
P/E
10.47
P/B
1.08
EV/EBITDA
4.82
RETURN ON EQUITY
1.8%
NET MARGIN
3.5%
DEBT/EQUITY
0.23
DIVIDEND YIELD
2.4%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
98.0%
FLOAT SHARES
18,393,354
AVG. DAILY VOLUME (30D)
22,597
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about Drägerwerk stock
What does Drägerwerk do?
Drägerwerk AG & Co. KGaA is a company in the Healthcare sector, Medical - Devices industry, headquartered in Germany.
The CEO is Stefan A. Drager, the company employs around 16,009 people.
The IPO was on 12/11/1998; the stock trades on XETRA under the ticker DRW3.DE.
When does Drägerwerk report next?
The next earnings date is 29/10/2026.
Around past earnings, price swings were roughly -6% stronger than usual.
Does Drägerwerk pay a dividend?
Yes. The last dividend was €2.27 per share, ex-date 11/05/2026, paid on 13/05/2026.
The dividend yield is 2.4% (as of 30/06/2026).
Which stocks are comparable to Drägerwerk?
Comparable stocks include Siemens Healthineers, Abbott Laboratories, Medtronic, Stryker, Boston Scientific, Edwards Lifesciences, DexCom and GE HealthCare Technologies.
How can I get Drägerwerk stock analyzed?
Clicking "Analyze stock" lets five strategies assess Drägerwerk against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.